CD8A and COVID-19: Whereas a typical host antiviral response involves the production of some proinflammatory cytokines and the activation of CD4+ and CD8+ T cells to control the infection, COVID-19 patients display an exacerbated cytokine production response with variable functionality of innate and adaptive lymphocytes.